3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Renal Cell
10
Neoplasms
8
Neoplasm Metastasis
8
Endometrial Neoplasms
6
Breast Neoplasms
6
Brain Neoplasms
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Prostatic Neoplasms
4
Melanoma
4
Lymphoma
4
Kidney Neoplasms
4
Glioblastoma
4
Advanced Cancer
4
Uterine Cervical Neoplasms
3
Sarcoma
3
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Glioma
3
Central Nervous System Neoplasms
3
Unspecified Childhood Solid Tumor, Protocol Specific
2
Solid Tumors
2
Small Cell Lung Carcinoma
2
Resistant Solid Malignancies
2
Pinealoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Interventions
temsirolimus
1
tegafur-gimeracil-oteracil
1
S 1 (combination)
1
Oxaliplatin
1
Epirubicin
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Patients With Advanced or Metastatic Solid Tumors
×
temsirolimus
×
Clear all
NCT02215720
2026-03-20
TORERO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Completed
45 enrolled